BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Receives $16.56 Consensus Price Target from Analysts
Shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Get Free Report) have received an average rating of “Moderate Buy” from the nine brokerages that are currently covering the stock, Marketbeat reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation to the company. The average twelve-month target price […]
More Stories
Black Doves Season 2 is Coming Soon! Release Date, Cast Members, and Production Updates
Good news! The release date for the popular spy-action drama Black Doves Season 2 is out. Keira Knightley is returning...
How to Enable AO3 Dark Mode? Sign-up and Login Process
Looking for possible ways to enable AO3 dark mode? Many readers want to read fanfiction in dark mode on Archive...
What Makes a Poolside Area Actually Comfortable to Spend Time In?
A pool can look fantastic and still have nobody sitting around it for very long. That usually has less to...
MX Player for PC: How the Android Video Player Behaves on a Desktop Screen
Most people know MX Player as the app that finally played that one weird video file their phone refused to...
Release Window for Blue Eye Samurai Season 2? Latest Updates and More
Blue Eye Samurai Season 2 is releasing soon on the most popular streaming platform, Netflix. If you are also a...
What is the Release Date for GTA 6? System Requirements and Updated Features
GTA 6 is finally arriving! After years of delays and speculation, Rockstar finally confirmed the game’s launch by the end...